Mark S. Link
Impact in
- Cardiology and Cardiovascular Medicine top 0.02%
- Cardiovascular Effects of Exercise
- Cardiomyopathy and Myosin Studies
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrhythmias and Treatments
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Emergency Medicine top 0.01%
- Cardiac Arrest and Resuscitation
Papers in
-
- Cardiovascular Effects of Exercise 123
- Cardiac pacing and defibrillation studies 94
- Cardiac electrophysiology and arrhythmias 89
- Cardiac Arrhythmias and Treatments 87
- Cardiomyopathy and Myosin Studies 70
- Atrial Fibrillation Management and Outcomes 30
- Cardiovascular Function and Risk Factors 23
-
- Cardiac Arrest and Resuscitation 81
- Co-authors
- Barry J. Maron (76 shared papers)N.A. Mark Estes (116 shared papers)Martin S. Maron (37 shared papers)James E. Udelson (15 shared papers)Steve R. Ommen (8 shared papers)Clyde W. Yancy (10 shared papers)Paul J. Wang (61 shared papers)Rick A. Nishimura (6 shared papers)
- Journals
- Circulation (62 papers)Journal of the American College of Cardiology (47 papers)Heart Rhythm (37 papers)Journal of Cardiovascular Electrophysiology (25 papers)The American Journal of Cardiology (24 papers)
- Partner nations
- United StatesItalyNetherlands
In The Last Decade
Mark S. Link
357 papers receiving 38.4k citations
Mark S. Link's Hit Papers
Peers
Comparison fields: 5 of 181
- Cardiology and Cardiovascular Medicine 26.6k
- Emergency Medicine 7.3k
- Orthopedics and Sports Medicine 1.7k
- Surgery 4.7k
- Critical Care and Intensive Care Medicine 519
Countries citing papers authored by Mark S. Link
This map shows the geographic impact of Mark S. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Link more than expected).
Fields of papers citing papers by Mark S. Link
This network shows the impact of papers produced by Mark S. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Link. The network helps show where Mark S. Link may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 377 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy Hit paper breakdown → | 2011 | 1815 |
| 2 | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure Hit paper breakdown → | 2022 | 1773 |
| 3 | 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Hit paper breakdown → | 2023 | 1455 |
| 4 | Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Hit paper breakdown → | 2020 | 1413 |
| 5 | Part 8: Adult Advanced Cardiovascular Life Support Hit paper breakdown → | 2010 | 1266 |
| 6 | 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities Hit paper breakdown → | 2012 | 1251 |
| 7 | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy Hit paper breakdown → | 2011 | 1022 |
| 8 | Part 7: Adult Advanced Cardiovascular Life Support Hit paper breakdown → | 2015 | 931 |
| 9 | Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction Hit paper breakdown → | 2006 | 846 |
| 10 | Part 1: Executive Summary Hit paper breakdown → | 2010 | 845 |
| 11 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary Hit paper breakdown → | 2020 | 831 |
| 12 | Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy Hit paper breakdown → | 2000 | 788 |
| 13 | Exercise and Acute Cardiovascular Events Hit paper breakdown → | 2007 | 775 |
| 14 | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary Hit paper breakdown → | 2011 | 677 |
| 15 | Recommendations for interpretation of 12-lead electrocardiogram in the athlete Hit paper breakdown → | 2009 | 636 |
| 16 | Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Hit paper breakdown → | 2007 | 629 |
| 17 | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary Hit paper breakdown → | 2022 | 623 |
| 18 | 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy Hit paper breakdown → | 2019 | 591 |
| 19 | Part 1: Executive Summary Hit paper breakdown → | 2015 | 586 |
| 20 | 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities Hit paper breakdown → | 2012 | 562 |
About Mark S. Link
Mark S. Link is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine, Orthopedics and Sports Medicine, Surgery and Biomedical Engineering, having authored 377 papers that have together received 40.6k indexed citations. Recurring topics across this work include Cardiovascular Effects of Exercise (123 papers), Cardiac pacing and defibrillation studies (94 papers), Cardiac electrophysiology and arrhythmias (89 papers), Cardiac Arrhythmias and Treatments (87 papers), Cardiac Arrest and Resuscitation (81 papers), Cardiomyopathy and Myosin Studies (70 papers), Atrial Fibrillation Management and Outcomes (30 papers) and Cardiovascular Function and Risk Factors (23 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (26.6k citations), Emergency Medicine (7.3k citations), Orthopedics and Sports Medicine (1.7k citations), Surgery (4.7k citations) and Critical Care and Intensive Care Medicine (519 citations). Mark S. Link has collaborated with scholars based in United States, Italy and Netherlands. Frequent co-authors include Barry J. Maron, N.A. Mark Estes, Martin S. Maron, James E. Udelson, Steve R. Ommen, Clyde W. Yancy, Paul J. Wang, Rick A. Nishimura, Robert O. Bonow and Jeffrey Allen Towbin. Their work appears in journals such as Circulation, Journal of the American College of Cardiology, Heart Rhythm, Journal of Cardiovascular Electrophysiology and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.